From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
May 18, 2020
Philadelphia, PA, May 18, 2020 – IntegriChain, a leading data and managed services company helping Life Sciences manufacturers deliver access to innovative therapies that significantly improve patient lives, today announced the company is prominently featured in Gartner’s new Market Guide for Revenue Management in Pharmaceuticals and Biotechnology, which is available here from the Gartner.com website. Following IntegriChain’s acquisition of the Life Sciences Division of Cumberland last month, the report highlights the combined company’s flexible and agile revenue management data, analytics, and managed services platform.
“We are excited to have significant presence in the Gartner Revenue Management Market Guide, highlighting our platform of rebate management, government pricing, and gross-to-net offerings,” said IntegriChain CEO Kevin Leininger. “As Gartner points out, a flexible and agile data and analytics platform — such as our ICyte platform — is ‘crucial’ to manufacturers who are implementing novel and outcomes-based contracts to address government and commercial payer pressure. Our powerful platform, in combination with the industry’s largest team of managed services professionals and revenue management subject matter experts, delivers the business insights necessary for these manufacturers to control revenue leakage, manage contract complexity, and solve their gross-to-net challenges.”
About IntegriChain IntegriChain delivers Life Sciences’ only comprehensive data and business process platform for market access. More than 220 manufacturers rely on IntegriChain’s analytics, applications, managed services and expert advisors to power their market access operations and harness the value of their channel, patient and payer data. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit www.integrichain.com, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
